VIVITRA 440MG INJECTION

Content Reviewed By:

Written By:

• The protein called HER2 (human epidermal growth factor receptor 2) is naturally present on many cells, acting like a receiver for growth signals. In some types of cancer, certain cancer cells have an unusually large number of these HER2 receivers on their surface. This excessive amount of HER2 constantly tells the cancer cells to grow and divide rapidly, leading to aggressive tumor growth. VIVITRA 440MG INJECTION is a targeted therapy specifically designed to address this issue. It works by recognizing and attaching itself directly to these extra HER2 proteins found on the surface of cancer cells. Think of it like a key fitting into a very specific lock, but in this case, the lock is the HER2 protein and VIVITRA 440MG INJECTION is the key that blocks it. Once VIVITRA 440MG INJECTION binds to HER2, it effectively blocks the growth signals that the protein would normally receive. By doing this, VIVITRA 440MG INJECTION helps to slow down or even stop the uncontrolled growth and spread of these HER2-positive cancer cells. This targeted approach means it focuses primarily on the cancer cells with too much HER2, aiming to minimize harm to healthy cells compared to some traditional treatments. It’s an important tool in fighting cancers driven by an overproduction of the HER2 protein.

• VIVITRA 440MG INJECTION is a medication that is given directly into your vein, a process known as an intravenous infusion. This treatment is typically administered either before or after a surgical procedure, depending on your specific medical condition and treatment plan as determined by your healthcare provider. The administration of VIVITRA 440MG INJECTION is a medical procedure that must be performed by a trained healthcare professional in a clinical setting, such as a hospital or clinic. The very first time you receive VIVITRA 440MG INJECTION, the infusion will usually take about 90 minutes. This slower initial rate allows your medical team to carefully monitor you for any potential reactions and ensure you tolerate the medication well. For all subsequent doses, if the first dose was tolerated without significant issues, the infusion time is often reduced and can be completed in about 30 minutes. It is crucial that you do not attempt to self-administer this medication; it requires professional expertise and monitoring. Your doctor or nurse will manage the entire process to ensure your safety and the effectiveness of the treatment.